Back to AQR CAPITAL MANAGEMENT LLC AQR CAPITAL MANAGEMENT LLC

ADCTADCT
8 quarters

Position history for AQR CAPITAL MANAGEMENT LLCAQR CAPITAL MANAGEMENT LLC's holdings in ADC THERAPEUTICS SA

AQR CAPITAL MANAGEMENT LLC holds 658,125 shares of ADCT (ADC THERAPEUTICS SA), worth $704,193 as of 2026-Q2. The position was increased (+176.9% shares). ADCT represents 0.0% of AQR CAPITAL MANAGEMENT LLC's portfolio.

Current Value

$704,193

Current Shares

658,125

Total Value Change

+$634,556

Total Shares Change

+636,018

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
658,125
+176.9%
$704,1930.0%$1.07
40
2026-Q1
Increased
237,637
+15.0%
$891,1410.0%$4.05
29
2025-Q4
Increased
206,576
+42.2%
$729,2140.0%$3.50
33
2025-Q3
Increased
145,252
+3.3%
$581,0080.0%$4.02
25
2025-Q2
Decreased
140,580
-30.1%
$376,7540.0%$2.71
0
2025-Q1
Increased
201,170
+411.1%
$283,6510.0%$1.49
38
2024-Q4
Increased
39,362
+78.0%
$78,3300.0%$1.90
32
2024-Q3
New
22,107
-
$69,6370.0%$3.08
29

Other major holders of ADCT: BAKER BROS. ADVISORS LP, ALLIANCEBERNSTEIN L.P., Magnetar Financial LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used